Eaton Vance Management’s Cardlytics CDLX Stock Holding History

Eaton Vance Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$312K	Hold	3,320	–	–	﹤0.01%	1420
2022 Q2	$741K	Hold	3,320	–	–	﹤0.01%	1312
2022 Q1	$1.82M	Hold	3,320	–	–	﹤0.01%	1210
2021 Q4	$2.19M	Hold	3,320	–	–	﹤0.01%	1005
2021 Q3	$2.79M	Hold	3,320	–	–	﹤0.01%	866
2021 Q2	$4.21M	Sell	3,320 -8	-0.2%	-$9.03K	0.01%	823
2021 Q1	$3.65M	Buy	+3,328	New	+$4.39M	0.01%	825

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.88B AUM 2.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

ACM

Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JCM

JS Capital Management New York $223M AUM 104.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Eaton Vance Management's CDLX Position: Q3 2022 in Review

Eaton Vance Management held its Cardlytics (CDLX) position steady in Q3 2022 at 3,320 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Eaton Vance Management first reported a position in CDLX in Q1 2021 and has held it in 7 quarters since. The position peaked at $4.21M in Q2 2021. 132 funds tracked by Wall St. Rank hold CDLX as of Q3 2022.

Eaton Vance Management held 3,320 shares of Cardlytics worth $312K as of Q3 2022.
Eaton Vance Management left its Cardlytics share count unchanged in Q3 2022.
Cardlytics made up ﹤0.01% of Eaton Vance Management's portfolio in Q3 2022, its #1420 holding.
Eaton Vance Management first reported a position in Cardlytics in Q1 2021 and has held it in 7 quarters since.
Eaton Vance Management's Cardlytics position peaked at $4.21M in Q2 2021.
132 funds tracked by Wall St. Rank held Cardlytics as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.